EBASTEL

This brand name is authorized in Brazil, Cyprus, Germany, Spain, Japan

Active ingredients

The drug EBASTEL contains one active pharmaceutical ingredient (API):

1 Ebastine UNII TQD7Q784P1 - EBASTINE

Ebastine has been shown to produce a rapid and long-lasting inhibition of histamine-induced effect and to have a strong affinity towards H1-receptors. Read about Ebastine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EBASTEL Film-coated tablet	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R06AX22	Ebastine	R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AX Other antihistamines for systemic use
Discover more medicines within R06AX22

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 508006602115311, 508006701131315, 508021070141007
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00027140, 00027157, 02249620, 02249637, 02249643, 02748955, 02748961, 02950869, 04260270, 04260287, 04260293, 04445940, 07117248, 07275705, 07275711, 07275728, 09284186, 09284200, 09284217, 09477057, 09477063, 10944564, 10944570, 15255645, 15255651, 15255668
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 58357, 58358, 63366, 66281, 66282
Country: JP	医薬品医療機器総合機構	Identifier(s): 4490019F1028, 4490019F2024, 4490019F3020, 4490019F4027